Home › NDC Lookup › Labelers › Qilu Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd. NDCs and Package Codes

This page lists NDC package records associated with labeler code 67184 (Qilu Pharmaceutical Co., Ltd.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

69
Package NDCs
57
Products
57
Active listings
0
Discontinued
27
Ingredients
0
Therapeutic classes
11
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
Olanzapine 7
Oxaliplatin 6
Tadalafil 4
Ceftriaxone Sodium 4
Palonosetron Hydrochloride 3
CEFEPIME HYDROCHLORIDE 3
Irinotecan Hydrochloride 3
Bortezomib 2
Pemetrexed disodium 2
mirabegron 2
By dosage form
INJECTION, SOLUTION 11
INJECTION, POWDER, LYOPHILIZED, FO... 10
INJECTION, POWDER, FOR SOLUTION 9
TABLET 8
TABLET, FILM COATED 5
INJECTION 4
POWDER 3
KIT 2

Browse records — 57 products

Drug / product Billing NDC NADAC / unit Status
Amikacin Sulfate 250 mg/mL INJECTION, SOLUTION Qilu · NDC 67184-0569-02 · 10 VIAL, GLASS in 1 CARTON (67184-0569-2) / 2 mL in 1 VIAL, GLASS (67184-0569-1) 67184-0569-02 — On market View →
Amikacin Sulfate 250 mg/mL INJECTION, SOLUTION Qilu · NDC 67184-0570-02 · 10 VIAL, GLASS in 1 CARTON (67184-0570-2) / 4 mL in 1 VIAL, GLASS (67184-0570-1) 67184-0570-02 — On market View →
Bortezomib 25 g/25g POWDER Qilu · NDC 67184-0026-01 · 25 g in 1 BOTTLE, GLASS (67184-0026-1) 67184-0026-01 — On market View →
Bumetanide .25 mg/mL INJECTION Qilu · NDC 67184-0594-02 · 10 VIAL in 1 CARTON (67184-0594-2) / 10 mL in 1 VIAL (67184-0594-1) 67184-0594-02 — On market View →
Bumetanide .25 mg/mL INJECTION Qilu · NDC 67184-0593-02 · 10 VIAL in 1 CARTON (67184-0593-2) / 4 mL in 1 VIAL (67184-0593-1) 67184-0593-02 — On market View →
Cefazolin 1 g/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1001-02 · 25 VIAL in 1 CARTON (67184-1001-2) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 67184-1001-02 — On market View →
Cefepime 500 mg/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1002-01 · 10 VIAL in 1 CARTON (67184-1002-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 67184-1002-01 — On market View →
Cefepime 1 g/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1003-01 · 10 VIAL in 1 CARTON (67184-1003-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 67184-1003-01 — On market View →
Cefepime 2 g/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1004-01 · 10 VIAL in 1 CARTON (67184-1004-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 67184-1004-01 — On market View →
Ceftriaxone Sodium 500 mg/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1006-01 · 10 VIAL, SINGLE-USE in 1 CARTON (67184-1006-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE 67184-1006-01 — On market View →
Ceftriaxone Sodium 2 g/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1008-01 · 10 VIAL, SINGLE-USE in 1 CARTON (67184-1008-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE 67184-1008-01 — On market View →
Ceftriaxone Sodium 1 g/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1007-01 · 10 VIAL, SINGLE-USE in 1 CARTON (67184-1007-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE 67184-1007-01 — On market View →
Ceftriaxone Sodium 250 mg/1 INJECTION, POWDER, FOR SOLUTION Qilu · NDC 67184-1005-01 · 10 VIAL, SINGLE-USE in 1 CARTON (67184-1005-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE 67184-1005-01 — On market View →
Cetrorelix acetate KIT Qilu · NDC 67184-0605-02 · 1 KIT in 1 CARTON (67184-0605-2) * 1 mL in 1 VIAL, GLASS (67184-0567-1) * 1 mL in 1 SYRINGE, GLASS (67184-0568-1) 67184-0605-02 — On market View →
Daptomycin 500 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Qilu · NDC 67184-0549-01 · 1 VIAL, SINGLE-USE in 1 CARTON (67184-0549-1) / 10 mL in 1 VIAL, SINGLE-USE 67184-0549-01 — On market View →
Decitabine 50 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Qilu · NDC 67184-0535-01 · 1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL 67184-0535-01 — On market View →
FOSAPREPITANT DIMEGLUMINE 150 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Qilu · NDC 67184-0540-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE 67184-0540-01 — On market View →
Ganirelix Acetate 250 ug/.5mL INJECTION, SOLUTION Qilu · NDC 67184-0574-01 · 1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS 67184-0574-01 — On market View →
Gefitinib 250 mg/1 TABLET, COATED Qilu · NDC 67184-0531-01 · 30 TABLET, COATED in 1 BOTTLE (67184-0531-1) 67184-0531-01 — On market View →
HYDROXYUREA 500 mg/1 CAPSULE Qilu · NDC 67184-0607-01 · 100 CAPSULE in 1 BOTTLE (67184-0607-1) 67184-0607-01 — On market View →
Icosapent Ethyl 1 g/1 CAPSULE Qilu · NDC 67184-0582-01 · 120 CAPSULE in 1 BOTTLE (67184-0582-1) 67184-0582-01 — On market View →
imatinib mesylate 400 mg/1 TABLET Qilu · NDC 67184-0533-01 · 30 TABLET in 1 BOTTLE (67184-0533-1) 67184-0533-01 — On market View →
imatinib mesylate 100 mg/1 TABLET Qilu · NDC 67184-0532-01 · 90 TABLET in 1 BOTTLE (67184-0532-1) 67184-0532-01 — On market View →
Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION Qilu · NDC 67184-0511-01 · 1 VIAL, SINGLE-USE in 1 CARTON (67184-0511-1) / 2 mL in 1 VIAL, SINGLE-USE 67184-0511-01 — On market View →
Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION Qilu · NDC 67184-0512-01 · 1 VIAL, SINGLE-USE in 1 CARTON (67184-0512-1) / 5 mL in 1 VIAL, SINGLE-USE 67184-0512-01 — On market View →
Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION Qilu · NDC 67184-0513-01 · 1 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) / 15 mL in 1 VIAL, SINGLE-USE 67184-0513-01 — On market View →
Melphalan Hydrochloride KIT Qilu · NDC 67184-0618-02 · 1 KIT in 1 CARTON (67184-0618-2) * 15 mL in 1 VIAL, SINGLE-DOSE (67184-0616-1) * 10 mL in 1 VIAL, SINGLE-USE (67184-0617-1) 67184-0618-02 — On market View →
MICAFUNGIN 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Qilu · NDC 67184-0590-01 · 1 VIAL in 1 CARTON (67184-0590-1) / 5 mL in 1 VIAL 67184-0590-01 — On market View →
MICAFUNGIN 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Qilu · NDC 67184-0589-01 · 1 VIAL in 1 CARTON (67184-0589-1) / 5 mL in 1 VIAL 67184-0589-01 — On market View →
Mirabegron 25 mg/1 TABLET, FILM COATED, EXTENDED RELEASE Qilu · NDC 67184-0571-01 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0571-1) 67184-0571-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.